, Tracking Stock Market Picks
Enter Symbol:
Biomimetic Therapeutics, Inc. (BMTI) [hlAlert]

up 11.64 %

Biomimetic Therapeutics, Inc. (BMTI) rated Buy with price target $24 by Wedbush Morgan

Posted on: Friday,  Mar 20, 2009  1:25 PM ET by Wedbush Morgan

Wedbush Morgan rated Buy Biomimetic Therapeutics, Inc. (NASDAQ: BMTI) on 03/20/2009, when the stock price was $8.50. Since
then, Biomimetic Therapeutics, Inc. has gained 11.65% as of 02/28/2013's recent price of $9.49.
If you would have followed this Wedbush Morgan's recommendation on BMTI, you would have gained 11.64% of your investment in 1441 days.

BioMimetic Therapeutics, Inc. (BioMimetic) develops and commercializes products to stimulate the body?s natural tissue regenerative process. The Company?s protein therapeutic-device combination products are used for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage. The Company?s platform regenerative technology, which incorporates a potent version of one of the body?s natural key stimulators of tissue repair, may offer physicians advanced biological solutions to actively stimulate tissue healing and regeneration. The Company focuses on developing GEM 21S technology to stimulate tissue healing in orthopedic applications (such as distal radius, or wrist, fractures and fusions of the bones in the foot and ankle to eliminate chronic pain from trauma or arthritis), and potentially spine and sports injury applications.

Since 1980, WEDBUSH has used its private equity discipline to invest in under-valued and capital constrained public and private companies that have a significant potential for appreciation. The firm invests with high quality management teams with domain expertise and expects management to retain or make a personally significant equity investment.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/20/2009 1:25 PM Buy
8.50 24.00
as of 12/31/2009
1 Week up  16.59 %
1 Month up  27.32 %
3 Months up  11.05 %
1 YTD up  59.52 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy